Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score.

Phillips AA, Shapira I, Willim RD, Sanmugarajah J, Solomon WB, Horwitz SM, Savage DG, Bhagat G, Soff G, Zain JM, Alobeid B, Seshan VE, O'Connor OA.

Cancer. 2010 Jul 15;116(14):3438-46. doi: 10.1002/cncr.25147.

PMID:
20564100
[PubMed - indexed for MEDLINE]
Free Article
2.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
[PubMed - indexed for MEDLINE]
3.

Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.

Gordon LI, Andersen J, Colgan J, Glick J, Resnick GD, O'Connell M, Cassileth PA.

Cancer. 1995 Feb 1;75(3):865-73.

PMID:
7530168
[PubMed - indexed for MEDLINE]
4.

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.

Savage KJ, Al-Rajhi N, Voss N, Paltiel C, Klasa R, Gascoyne RD, Connors JM.

Ann Oncol. 2006 Jan;17(1):123-30. Epub 2005 Oct 19.

PMID:
16236753
[PubMed - indexed for MEDLINE]
Free Article
5.

Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.

Escalón MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL, Dang NH.

Cancer. 2005 May 15;103(10):2091-8.

PMID:
15816054
[PubMed - indexed for MEDLINE]
Free Article
6.

Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T-cell leukemia/lymphoma.

Sakamoto FH, Colleoni GW, Teixeira SP, Yamamoto M, Michalany NS, Almeida FA, Chiba AK, Petri V, Fernandes MA, Pombo-de-Oliveira MS.

Int J Dermatol. 2006 Apr;45(4):447-9.

PMID:
16650175
[PubMed - indexed for MEDLINE]
7.

Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.

Kchour G, Makhoul NJ, Mahmoudi M, Kooshyar MM, Shirdel A, Rastin M, Rafatpanah H, Tarhini M, Zalloua PA, Hermine O, Farid R, Bazarbachi A.

Leuk Lymphoma. 2007 Feb;48(2):330-6.

PMID:
17325893
[PubMed - indexed for MEDLINE]
8.

VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.

Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, Ikeda S, Masuda M, Nagoshi H, Ueda R, Tamura K, Sano M, Momita S, Yamaguchi K, Kawano F, Hanada S, Tobinai K, Shimoyama M, Hotta T, Tomonaga M; Japan Clinical Oncology Group Study JCOG9801.

J Clin Oncol. 2007 Dec 1;25(34):5458-64. Epub 2007 Oct 29.

PMID:
17968021
[PubMed - indexed for MEDLINE]
Free Article
9.

Adult T-cell leukemia/lymphoma in a Korean--a case report.

Lee SS, Hong SI, Lee DS, Kang YK, Kim CW, Jang JJ.

J Korean Med Sci. 1994 Dec;9(6):458-65.

PMID:
7786441
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

HTLV-1 and associated adult T-cell leukemia/lymphoma.

Mahieux R, Gessain A.

Rev Clin Exp Hematol. 2003 Dec;7(4):336-61. Review.

PMID:
15129647
[PubMed - indexed for MEDLINE]
11.

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification.

Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM.

Ann Oncol. 2004 Oct;15(10):1467-75.

PMID:
15367405
[PubMed - indexed for MEDLINE]
Free Article
12.

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.

Ai Zheng. 2006 Dec;25(12):1543-9. Chinese.

PMID:
17166383
[PubMed - indexed for MEDLINE]
13.

THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study.

Takamatsu Y, Suzumiya J, Utsunomiya A, Maeda K, Matsuoka H, Suzushima H, Tsukada J, Shibata K, Tamura K; Kyushu Hematology Organization for Treatment Study Group (K-HOT).

Eur J Haematol. 2010 May;84(5):391-7. doi: 10.1111/j.1600-0609.2010.01411.x. Epub 2010 Jan 5.

PMID:
20059527
[PubMed - indexed for MEDLINE]
14.

New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types.

Amano M, Kurokawa M, Ogata K, Itoh H, Kataoka H, Setoyama M.

J Dermatol. 2008 May;35(5):270-5. doi: 10.1111/j.1346-8138.2008.00465.x.

PMID:
18477226
[PubMed - indexed for MEDLINE]
15.

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.

Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN, Trigg ME, Uckun FM, Bleyer WA.

Cancer. 1998 Feb 1;82(3):600-12.

PMID:
9452280
[PubMed - indexed for MEDLINE]
16.

Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.

Velasquez WS, McLaughlin P, Fuller LM, Allen PK, Tucker SL, Swan F Jr, Rodriguez MA, Hagemeister FB, Cabanillas FF.

Cancer. 1994 May 1;73(9):2408-16.

PMID:
7513251
[PubMed - indexed for MEDLINE]
17.

Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.

Hodson A, Crichton S, Montoto S, Mir N, Matutes E, Cwynarski K, Kumaran T, Ardeshna KM, Pagliuca A, Taylor GP, Fields PA.

J Clin Oncol. 2011 Dec 10;29(35):4696-701. doi: 10.1200/JCO.2011.35.5578. Epub 2011 Oct 31.

PMID:
22042945
[PubMed - indexed for MEDLINE]
Free Article
18.

Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.

Waits TM, Greco FA, Greer JP, Johnson DH, Wolff SN, Stein RS, McMaster ML, Hainsworth JD.

J Clin Oncol. 1993 May;11(5):943-9.

PMID:
7683712
[PubMed - indexed for MEDLINE]
Free Article
19.

Human T-cell lymphotropic virus type I and adult T-cell leukemia/lymphoma outside Japan and the Caribbean Basin.

Levine PH, Jaffe ES, Manns A, Murphy EL, Clark J, Blattner WA.

Yale J Biol Med. 1988 May-Jun;61(3):215-22.

PMID:
3262954
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk